RO 3306
Key | Value |
---|---|
Synonyms: | 872573-93-8 CDK1 INHIBITOR IV, RO-3306 CHEMBL393929 RO 3306 RO-3306 |
National Service Center# (NSC#):1,2 | NA |
CAS#: | NA |
PubChem Substance#: | NA |
PubChem Compound#: | NA |
Mechanism of Action: | NA |
Status: | NA |
Molecular Formula: | NA |
Smiles: | NA |
RO 3306 is in CellMinerCDB, a searchable tool integrating cancer cell line pharmacogenomics data to link gene and drug activity signatures.
Click Here to Access CellMinerCDB
If you use content from this page, CellMinerCDB or CellMiner (NCI-60), please cite: Luna A et al. 2021. PMID: 33196823, Rajapakse VN et al. 2018. PMID: 30553813, Luna et al. 2016., PMID: 26635141, and Reinhold et al. 2012., PMID: 22802077.
Available Data
Visit CellMinerCDB to interactively explore available pharmacogenomics data for RO 3306.
NCI60 | HTS384 NCI60 | GDSC-MGH-Sanger | GDSC1 drugs | GDSC2 drugs | CCLE-Broad-MIT | CTRP-Broad-MIT | NCI-DTP SCLC | PRISM-Broad-MIT | NCI60-DTP Almanac | NCATS IC50 | NCATS AUC |
---|---|---|---|---|---|---|---|---|---|---|---|
NA | NA | RO-3306 | RO-3306 | RO-3306 | NA | NA | NA | NA | NA | NA | NA |
2 Most structures have a unique NSC number but over the years a small percentage of structures or agents may have been assigned more than one NSC number. In the case of salts, different salt forms (e.g. HCl, HOAc) are designated with separate NSC numbers.